-
Je něco špatně v tomto záznamu ?
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations
A. Xochelli, V. Bikos, E. Polychronidou, C. Galigalidou, A. Agathangelidis, F. Charlotte, P. Moschonas, Z. Davis, M. Colombo, M. Roumelioti, LA. Sutton, P. Groenen, M. van den Brand, M. Boudjoghra, P. Algara, A. Traverse-Glehen, A. Ferrer, E....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30484876
DOI
10.1002/path.5209
Knihovny.cz E-zdroje
- MeSH
- genová přestavba B-lymfocytů genetika MeSH
- geny pro imunoglobuliny genetika MeSH
- geny pro těžké řetězce imunoglobulinů genetika MeSH
- hypervariabilní oblasti genetika MeSH
- lidé MeSH
- lymfom z B-buněk marginální zóny genetika MeSH
- mutace genetika MeSH
- nádorové mikroprostředí MeSH
- receptory antigenů B-buněk genetika MeSH
- variabilní oblast imunoglobulinu genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SMZL), nodal (NMZL) and extranodal (ENMZL), as well as provisional entities (n = 76), according to the WHO classification. The most striking Ig gene repertoire skewing was observed in SMZL. However, restrictions were also identified in all other MZ lymphomas studied, particularly ENMZL, with significantly different Ig gene distributions depending on the primary site of involvement. Cross-entity comparisons of the MZ Ig sequence dataset with a large dataset of Ig sequences (MZ-related or not; n = 65 837) revealed four major clusters of cases sharing homologous ('public') heavy variable complementarity-determining region 3. These clusters included rearrangements from SMZL, ENMZL (gastric, salivary gland, ocular adnexa), chronic lymphocytic leukemia, but also rheumatoid factors and non-malignant splenic MZ cells. In conclusion, different MZ lymphomas display biased immunogenetic signatures indicating distinct antigen exposure histories. The existence of rare public stereotypes raises the intriguing possibility that common, pathogen-triggered, immune-mediated mechanisms may result in diverse B lymphoproliferations due to targeting versatile progenitor B cells and/or operating in particular microenvironments. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
1st Department of Propaedeutic Medicine University of Athens Athens Greece
Central European Institute of Technology Masaryk University Brno Czech Republic
Centre for Cancer Research and Cell Biology Queen's University Belfast Belfast UK
Department of Haematology Athens Medical Center Athens Greece
Department of Haematology Royal Bournemouth Hospital Bournemouth UK
Department of Haematology University of Crete Heraklion Greece
Department of Hematology Hopital Pitie Salpetriere and Sorbonne University Paris France
Department of Immunology Genetics and Pathology Uppsala University Uppsala Sweden
Department of Informatics Ionian University Corfu Greece
Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden
Department of Pathology and Hematology Hospices Civils de Lyon Universite Lyon 1 Lyon France
Department of Pathology Hopital Pitie Salpetriere and Sorbonne University Paris France
Department of Pathology Radboud University Medical Center Nijmegen The Netherlands
Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece
Hematology Department Nikea General Hospital Piraeus Greece
Hematopathology Department Evangelismos Hospital Athens Greece
Hospital Virgen de la Salud Toledo Spain
Information Technologies Institute CERTH Thessaloniki Greece
Institute of Applied Biosciences CERTH Thessaloniki Greece
Molecular Pathology Ospedale Policlinico SanMartino Genoa Italy
Pathology Department IIS 'Fundacion Jimenez Diaz' Madrid Spain
Pathology Unit San Raffaele Scientific Institute Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045111
- 003
- CZ-PrNML
- 005
- 20200120092133.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/path.5209 $2 doi
- 035 __
- $a (PubMed)30484876
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Xochelli, Aliki $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- 245 10
- $a Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations / $c A. Xochelli, V. Bikos, E. Polychronidou, C. Galigalidou, A. Agathangelidis, F. Charlotte, P. Moschonas, Z. Davis, M. Colombo, M. Roumelioti, LA. Sutton, P. Groenen, M. van den Brand, M. Boudjoghra, P. Algara, A. Traverse-Glehen, A. Ferrer, E. Stalika, M. Karypidou, G. Kanellis, C. Kalpadakis, M. Mollejo, G. Pangalis, P. Vlamos, RM. Amini, S. Pospisilova, D. Gonzalez, M. Ponzoni, A. Anagnostopoulos, V. Giudicelli, MP. Lefranc, B. Espinet, P. Panagiotidis, MA. Piris, MQ. Du, R. Rosenquist, T. Papadaki, C. Belessi, M. Ferrarini, D. Oscier, D. Tzovaras, P. Ghia, F. Davi, A. Hadzidimitriou, K. Stamatopoulos,
- 520 9_
- $a The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SMZL), nodal (NMZL) and extranodal (ENMZL), as well as provisional entities (n = 76), according to the WHO classification. The most striking Ig gene repertoire skewing was observed in SMZL. However, restrictions were also identified in all other MZ lymphomas studied, particularly ENMZL, with significantly different Ig gene distributions depending on the primary site of involvement. Cross-entity comparisons of the MZ Ig sequence dataset with a large dataset of Ig sequences (MZ-related or not; n = 65 837) revealed four major clusters of cases sharing homologous ('public') heavy variable complementarity-determining region 3. These clusters included rearrangements from SMZL, ENMZL (gastric, salivary gland, ocular adnexa), chronic lymphocytic leukemia, but also rheumatoid factors and non-malignant splenic MZ cells. In conclusion, different MZ lymphomas display biased immunogenetic signatures indicating distinct antigen exposure histories. The existence of rare public stereotypes raises the intriguing possibility that common, pathogen-triggered, immune-mediated mechanisms may result in diverse B lymphoproliferations due to targeting versatile progenitor B cells and/or operating in particular microenvironments. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 650 _2
- $a hypervariabilní oblasti $x genetika $7 D022801
- 650 _2
- $a genová přestavba B-lymfocytů $x genetika $7 D015322
- 650 _2
- $a geny pro imunoglobuliny $x genetika $7 D005803
- 650 _2
- $a geny pro těžké řetězce imunoglobulinů $x genetika $7 D050438
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a variabilní oblast imunoglobulinu $x genetika $7 D007135
- 650 _2
- $a lymfom z B-buněk marginální zóny $x genetika $7 D018442
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a receptory antigenů B-buněk $x genetika $7 D011947
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bikos, Vasilis $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Polychronidou, Eleftheria $u Information Technologies Institute, CERTH, Thessaloniki, Greece. Department of Informatics, Ionian University, Corfu, Greece.
- 700 1_
- $a Galigalidou, Chrysi $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
- 700 1_
- $a Agathangelidis, Andreas $u Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy.
- 700 1_
- $a Charlotte, Frédéric $u Department of Pathology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
- 700 1_
- $a Moschonas, Panagiotis $u Information Technologies Institute, CERTH, Thessaloniki, Greece.
- 700 1_
- $a Davis, Zadie $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
- 700 1_
- $a Colombo, Monica $u Molecular Pathology, Ospedale Policlinico SanMartino, Genoa, Italy.
- 700 1_
- $a Roumelioti, Maria $u First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
- 700 1_
- $a Sutton, Lesley-Ann $u Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Groenen, Patricia $u Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a van den Brand, Michiel $u Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a Boudjoghra, Myriam $u Department of Hematology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
- 700 1_
- $a Algara, Patricia $u Hospital Virgen de la Salud, Toledo, Spain.
- 700 1_
- $a Traverse-Glehen, Alexandra $u Department of Pathology and Hematology, Hospices Civils de Lyon Universite Lyon 1, Lyon, France.
- 700 1_
- $a Ferrer, Ana $u Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
- 700 1_
- $a Stalika, Evangelia $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
- 700 1_
- $a Karypidou, Maria $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
- 700 1_
- $a Kanellis, George $u Hematopathology Department, Evangelismos Hospital, Athens, Greece.
- 700 1_
- $a Kalpadakis, Christina $u Department of Haematology, University of Crete, Heraklion, Greece.
- 700 1_
- $a Mollejo, Manuella $u Hospital Virgen de la Salud, Toledo, Spain.
- 700 1_
- $a Pangalis, Gerasimos $u Department of Haematology, Athens Medical Center, Athens, Greece.
- 700 1_
- $a Vlamos, Panayiotis $u Department of Informatics, Ionian University, Corfu, Greece.
- 700 1_
- $a Amini, Rose-Marie $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- 700 1_
- $a Pospisilova, Sarka $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Gonzalez, David $u Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
- 700 1_
- $a Ponzoni, Maurilio $u Pathology Unit, San Raffaele Scientific Institute, Milan, Italy.
- 700 1_
- $a Anagnostopoulos, Achilles $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
- 700 1_
- $a Giudicelli, Véronique $u IMGT®, the international ImMunoGeneTics Information System®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UMR CNRS UM, Montpellier, France.
- 700 1_
- $a Lefranc, Marie-Paule $u IMGT®, the international ImMunoGeneTics Information System®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UMR CNRS UM, Montpellier, France.
- 700 1_
- $a Espinet, Blanca $u Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
- 700 1_
- $a Panagiotidis, Panagiotis $u First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
- 700 1_
- $a Piris, Miguel Angel $u Pathology Department, IIS 'Fundacion Jimenez Diaz', Madrid, Spain.
- 700 1_
- $a Du, Ming-Qing $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Rosenquist, Richard $u Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Papadaki, Theodora $u Hematopathology Department, Evangelismos Hospital, Athens, Greece.
- 700 1_
- $a Belessi, Chrysoula $u Hematology Department, Nikea General Hospital, Piraeus, Greece.
- 700 1_
- $a Ferrarini, Manlio $u Direzione Scientifica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-IST, Genoa, Italy.
- 700 1_
- $a Oscier, David $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
- 700 1_
- $a Tzovaras, Dimitrios $u Information Technologies Institute, CERTH, Thessaloniki, Greece.
- 700 1_
- $a Ghia, Paolo $u Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy.
- 700 1_
- $a Davi, Frederic $u Department of Hematology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
- 700 1_
- $a Hadzidimitriou, Anastasia $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- 700 1_
- $a Stamatopoulos, Kostas $u Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- 773 0_
- $w MED00002878 $t The Journal of pathology $x 1096-9896 $g Roč. 247, č. 4 (2019), s. 416-421
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30484876 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200120092509 $b ABA008
- 999 __
- $a ok $b bmc $g 1483380 $s 1083784
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 247 $c 4 $d 416-421 $e 20190130 $i 1096-9896 $m Journal of pathology $n J Pathol $x MED00002878
- LZP __
- $a Pubmed-20200109
